Company: RNAC
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001140361-25-039793
Chunk: 2

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01      Regulation FD Disclosure.  

On October 30, 2025, the Company issued a press release announcing Dr. Brunn’s appointment as Chairman of the Board. A copy of the press release is
attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated by reference herein.

The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.